Newsroom

March 2019

• 
  Story Mar 25, 2019 From Our Labs

  What goes wrong with the window to the soul in glaucoma?

  Speaking with Ganesh Prasanna, Director of Ophthalmology at NIBR.

• Ad hoc release Mar 22, 2019

  Novartis plans for Alcon spin-off on April 9, 2019

  Alcon obtained approval for listing on SIX Swiss Exchange and New York Stock Exchange Alcon will seek effectiveness of Form 20-F registration statement from the US Securities and Exchange…
• 
  Story Mar 21, 2019 Discovery

  Experimental gene therapy discovered in-house enters clinical testing

  Novartis is taking its investigational gene therapy for a degenerative eye disease into clinical trials.

• In The News Mar 20, 2019

  It's Time to "Pivot Towards Transformational Innovation"

  In this interview with Susie Gharib from Fortune, Vas Narasimhan, CEO of Novartis, shares his perspective on changing the culture within Novartis.
• 
  Story Mar 19, 2019 Discovery

  Visualizing immuno-oncology research

  Learn how Novartis researchers are working to outsmart tumors.

• Press release Mar 18, 2019

  Alcon Announces Acquisition of PowerVision, Inc.

   Acquisition demonstrates Alcon's commitment to driving growth and innovation in advanced technology intraocular lenses (AT-IOLS) to meet the needs of cataract surgery patients who desire…
• Press release Mar 14, 2019

  Novartis joins the Global Chagas Disease Coalition and also announces first multinational, prospective, randomized study in people with chronic Chagas cardiomyopathy

  Study is planned to assess efficacy and safety of Entresto® (sacubitril / valsartan) vs enalapril in 900 patients with chronic Chagas cardiomyopathy; recruitment is planned to commence within 2019…
• Featured News Mar 14, 2019

  Global Equal Parental Leave Policy for all Novartis parents

  Fourteen weeks. That’s how many weeks all new Novartis parents will get as minimum paid parental leave, regardless of gender, rolling out from July 1, 2019.

• Ad hoc release Mar 14, 2019

  Novartis announces change in Sandoz leadership

  Richard Francis, CEO Sandoz, to step down on March 31, 2019  Francesco Balestrieri, Head Region Europe, Sandoz, appointed ad-interim CEO Sandoz Basel, March 14, 2019 - Novartis announced…
• Press release Mar 11, 2019

  Three winners of 2019 Sandoz Healthcare Access Challenge (HACk) are announced at SXSW

  Sandoz commits to increasing support from one winner to three, following impressive pitches from the finalists Winning ideas proposed innovative uses of artificial intelligence, mobile apps and…
• 
  Story Mar 07, 2019 People and Culture

  Enabling 130,000 employees to grow in an organization committed to continuous learning

  Our Chief Learning Officer, Simon Brown, talks about our ongoing efforts to build new capabilities by investing in our own people.

• Press release Mar 05, 2019

  Novartis Cosentyx® shows superior improvements in psoriasis patients' quality of life versus Janssen's IL-23 Stelara®*

  New CLARITY data show over two-thirds of Cosentyx (secukinumab) treated patients with moderate to severe psoriasis reported no impact of skin disease on their quality of life (QoL) up to Week 16…